Your browser doesn't support javascript.
loading
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104).
Xu, Song-Tao; Xi, Jun-Jie; Zhong, Wen-Zhao; Mao, Wei-Min; Wu, Lin; Shen, Yi; Liu, Yong-Yu; Chen, Chun; Cheng, Ying; Xu, Lin; Wang, Jun; Fei, Ke; Li, Xiao-Fei; Li, Jian; Huang, Cheng; Liu, Zhi-Dong; Xu, Shun; Chen, Ke-Neng; Xu, Shi-Dong; Liu, Lun-Xu; Yu, Ping; Wang, Bu-Hai; Ma, Hai-Tao; Yan, Hong-Hong; Yang, Xue-Ning; Zhang, Yong-Xing; Yin, Jia-Cheng; Wang, Qun; Wu, Yi-Long.
Afiliación
  • Xu ST; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xi JJ; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhong WZ; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Mao WM; Zhejiang Cancer Hospital, Hangzhou, China.
  • Wu L; Hunan Cancer Hospital, Changsha, China.
  • Shen Y; The Affiliated Hospital of Medical College, Qingdao University, Qingdao, China.
  • Liu YY; Liaoning Cancer Hospital, Shenyang, China.
  • Chen C; Fujian Medical University Union Hospital, Fuzhou, China.
  • Cheng Y; Jilin Provincial Cancer Hospital, Changchun, China.
  • Xu L; Jiangsu Cancer Hospital, Nanjing, China.
  • Wang J; The People's Hospital of Peking University, Beijing, China.
  • Fei K; Shanghai Pulmonary Hospital, Shanghai, China.
  • Li XF; Tangdu Hospital, Xi'an, China.
  • Li J; Peking University First Hospital, Beijing, China.
  • Huang C; Fujian Cancer Hospital, Fuzhou, China.
  • Liu ZD; Beijing Chest Hospital, Beijing, China.
  • Xu S; The First Hospital of China Medical University, Shenyang, China.
  • Chen KN; Beijing Cancer Hospital, Beijing, China.
  • Xu SD; The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
  • Liu LX; West China Hospital of Sichuan University, Chengdu, China.
  • Yu P; Sichuan Cancer Hospital, Chengdu, China.
  • Wang BH; The Northern Jiangsu People's Hospital, Yangzhou, China.
  • Ma HT; The First Affiliated Hospital of Suzhou University, Suzhou, China.
  • Yan HH; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yang XN; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhang YX; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yin JC; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang Q; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China. Electronic address: syylwu@live.cn.
J Thorac Oncol ; 14(3): 503-512, 2019 03.
Article en En | MEDLINE | ID: mdl-30521970
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioterapia Adyuvante / Carcinoma de Pulmón de Células no Pequeñas / Análisis Espacio-Temporal / Gefitinib / Neoplasias Pulmonares / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioterapia Adyuvante / Carcinoma de Pulmón de Células no Pequeñas / Análisis Espacio-Temporal / Gefitinib / Neoplasias Pulmonares / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos